Diabetes and stroke: Part two - Treating diabetes and stress hyperglycemia in hospitalized stroke patients

被引：5

作者：

Burroughs V. ^{[1
]}

Weinberger J. ^{[1
]}

机构：

[1] Department of Medicine, North General Hospital, New York, NY 10035-2709

来源：

Current Cardiology Reports | 2006年 / 8卷 / 1期

关键词：

Stroke Patient; Insulin Dose; Subcutaneous Insulin; Correction Dose; Stress Hyperglycemia;

D O I：

10.1007/s11886-006-0007-0

中图分类号：

学科分类号：

摘要：

It is well established that strict glycemic control for the hospitalized stroke patient is associated with improved outcome compared with poor control. This is particularly true for the stroke patients because hyperglycemia can adversely affect ischemic damage. A blood sugar level of less than 110 mg/dL is recommended for critically ill patients and should be achieved by intravenous insulin administration in an intensive care unit setting. Many stroke patients are unable to swallow, and insulin requirement must be readjusted carefully to conform to the nutritional state of the patient. The transition from intravenous insulin to subcutaneous insulin or oral antihyperglycemic agents must be carefully monitored. Careful discharge planning of diabetic care for the stroke patient is necessary to prevent long-term sequelae of inadequate control. Copyright © 2006 by Current Science Inc.

引用

页码：29 / 32

页数：3

共 26 条

[1]

Van den Berghe G., Wouters P., Weekers F., Et al., Intensive insulin therapy in critically ill patients, N Engl J Med, 345, pp. 1359-1367, (2001)

[2]

Stagnaro-Green A., Barton M.K., Linekin P.L., Et al., Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia, Mt Sinai J Med, 62, pp. 422-426, (1995)

[3]

Capes S.E., Hunt D., Malmberg K., Gerstein H.C., Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview, Lancet, 355, pp. 773-778, (2000)

[4]

Finney S.J., Zekveld C., Elia A., Evans T.W., Glucose control and mortality in critically ill patients, JAMA, 290, pp. 2041-2047, (2003)

[5]

Furnary A.P., Wu Y., Bookin S.O., Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Portland Diabetic Project, Endocr Pract, 10, SUPPL. 2, pp. 21-33, (2004)

[6]

Almbrand B., Johannesson M., Sjostrand B., Et al., Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus: Results from the DIGAMI study, Eur Heart J, 21, pp. 733-739, (2000)

[7]

Clement S., Braithwaite S.S., Magee M.F., Et al., Management of diabetes and hyperglycemia in hospitals, Diabetes Care, 27, pp. 553-591, (2004)

[8]

Garber A.J., Moghissi E.S., Bransome E.D., Et al., American College of Endocrinology position statement on inpatient diabetes and metabolic control, Endocr Pract, 10, pp. 77-82, (2004)

[9]

Dandona P., Aljada A., Bandyopadhyay A., The potential therapentic role of insulin in acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year, J Am Coll Cardiol, 26, pp. 57-65, (1995)

[10]

Le Roith D., Molecular mechanisms by which metabolic control may improve outcomes, Endocr Pract, 10, SUPPL. 2, pp. 57-62, (2004)

← 1 2 3 →